New medications for uterine fibroid treatment includes both Myfembree and Oriahann.
The most important step is to determine if you have uterine fibroids, their size, their location, their growth pattern, and whether you have normal bleeding patterns.
Thyroid problems, uterine endometrial lining disorders, and bleeding disorders can all be the cause of heavy bleeding that is not related to uterine fibroids…but can occur at the same time as uterine fibroids: so be checked for these conditions as well!
Orhiann has elagolix, estradiol and northindrone in each pill. It is indicated for the treatment of heavy menstrual bleeding in premenopausal women with uterine fibroids.
Myfembree has relugolix, estradiol, and norethindrone, and is also indicated for the same treatment reasons as Orhiann.
Both provide excellent contraceptive protection when taken consistently.
Both medications may be considered second line therapies for uterine fibroids, because of their side effect profile, more traditional medicines can be tried first.
Both medications would have potent protection against endometriosis as well as uterine fibroid treatment.
Both medications have the same amount of estrogen and the progesterone northindrone, and both have the same warnings about potential blood clotting disorders and vascular events including DVT strokes, myocardial infarctions, and pulmonary embolism.
It is recommended that women have assessment of their bone density at baseline and thereafter, and not use the medications for over 24 months because of potential bone loss.
Possible side effects of these medications include hot flashes, sweating, lack of menstrual periods and the inability to recognize that you are pregnant, uterine bleeding, hair loss and decreased libido.
But the best news is that women may notice that their periods are literally half as heavy as they were prior to using the medication.
Women who are anemic because of the amount of bleeding can find that they have their anemia stabilized as the bleeding is so well controlled.